Marvin 08130817192D 28 30 0 0 0 0 999 V2000 -0.7145 -0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -0.7145 0.4125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.0000 -0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 0.7145 -0.4125 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -5.7156 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -4.2868 1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.0011 2.0625 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.0011 2.8875 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 -5.7156 1.6500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -6.4301 2.0625 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 -5.0011 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -5.0011 -0.4125 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 -4.2868 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -3.5723 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -2.8578 1.6499 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 -2.8578 0.8250 0.0000 C 0 0 1 0 0 0 0 0 0 0 0 0 -2.1434 0.4125 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 -1.4289 1.6499 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 -1.4289 0.8250 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.9838 0.0000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.4990 0.6675 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 1.4990 -0.6674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 1.9260 -2.2610 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 2.5094 -1.6776 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 1.7126 -1.4642 0.0000 C 0 0 3 0 0 0 0 0 0 0 0 0 1.1293 -2.0476 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0 2 1 1 0 0 0 0 21 2 1 0 0 0 0 3 2 1 0 0 0 0 1 4 1 0 0 0 0 3 5 1 0 0 0 0 23 5 2 0 0 0 0 5 6 1 0 0 0 0 4 6 1 0 0 0 0 6 24 1 0 0 0 0 11 7 2 0 0 0 0 7 13 1 0 0 0 0 9 8 2 0 0 0 0 15 8 1 0 0 0 0 9 11 1 0 0 0 0 9 10 1 0 0 0 0 11 12 1 0 0 0 0 13 15 2 0 0 0 0 13 14 1 0 0 0 0 15 16 1 0 0 0 0 16 18 1 0 0 0 0 18 17 1 1 0 0 0 18 19 1 0 0 0 0 19 21 1 0 0 0 0 21 20 2 0 0 0 0 23 22 1 0 0 0 0 24 22 2 0 0 0 0 24 27 1 0 0 0 0 27 25 1 0 0 0 0 27 26 1 0 0 0 0 27 28 1 0 0 0 0 M END > CHEBI:40237 > sitagliptin > A triazolopyrazine that exhibits hypoglycemic activity. > 3 > MK-0431; (2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE > (3R)-3-amino-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)butan-1-one > sitagliptinum; sitagliptine; sitagliptina; sitagliptin > C16H15F6N5O > 407.31382 > 407.11808 > 0 > N[C@@H](CC(=O)N1CCn2c(C1)nnc2C(F)(F)F)Cc1cc(F)c(F)cc1F > InChI=1S/C16H15F6N5O/c17-10-6-12(19)11(18)4-8(10)3-9(23)5-14(28)26-1-2-27-13(7-26)24-25-15(27)16(20,21)22/h4,6,9H,1-3,5,7,23H2/t9-/m1/s1 > MFFMDFFZMYYVKS-SECBINFHSA-N > 486460-32-6 > 9962060 > 486460-32-6 > DB01261 > D08516 > LSM-5363 > 715 > Sitagliptin > 23286208; 23331339; 23432786; 23489256; 23927568; 24039399; 24041927 $$$$